Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma

NCT03068351

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Emory Uni - Winship Cancer Center; Hematology/Oncology Atlanta, Georgia, United States
View Trial Details
Completed

A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia

NCT02071225

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital De Txagorritxu; Servicio de Hematologia Vitoria-Gasteiz, Alava, Spain
  • Hospital General Universitario de Elche; Servicio de Hematologia Elche, Alicante, Spain
  • Hospital Universitari Germans Trias i Pujol; Servicio de Hematologia Badalona, Barcelona, Spain
  • Hospital Mutua de Terrassa; Servicio de Hematologia Terrassa, Barcelona, Spain
View all 21 locations
View Trial Details
Completed

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

NCT00003954

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Denver, Colorado, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Torino Torino, Italy
View Trial Details
Completed

Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression

NCT03525665

Conditions
Disease Attributes, Disease Progression, Follicular Lymphoma, +13 more
Locations
  • U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT Trani, BT, Italy
  • Azienda Ospedaliera S. Gerardo Di Monza Monza, Monza Brianza, Italy
  • CROB Rionero in Vulture, Potenza, Italy
  • Università Cattolica del Sacro Cuore - Policlinico "A. Gemelli" Roma, RM, Italy
View all 27 locations
View Trial Details
Completed

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

NCT00656305

Conditions
Blood Protein Disorders, Bone Diseases, Bone Metastases, +42 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University MRI & Diagnostic Imaging Centers Boca Raton, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 14 locations
View Trial Details
Completed

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

NCT00088530

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Robert A. Moss, M.D., FACP, Inc. Fountain Valley, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Watson Clinic for Cancer Care and Research Lakeland, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 99 locations
View Trial Details

Related conditions